Details for 2022153621

Up to date per 01.04.2026

Actions

Title / Product Name

CD62LLOW CD4+ T-ZELLEN ZUR BEHANDLUNG ODER VORBEUGUNG VON KREBS

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2022153621

EP Publication Number

4039260

E-Number

1676603

Language

PCT Number

Publication Date

10.08.2022 A

17.04.2024 B1

Registration Date

17.04.2024

AT Publication Date

15.05.2024

Application Date

06.02.2018

Registration Number

Priorities

07.02.2017

2017020685

02.06.2017

2017110069

IPC

A61K 35/17 20150101AFI20220624BHEP

Maximum Duration of Protection

06.02.2038

Owner

Saitama Medical University38, Morohongo Moroyama-machi Iruma-gun, Saitama 350-0495JP

Representative

No representatives present

Inventor

KAGAMU, Hiroshi Iruma-gun Saitama 350-0495JP